[Effects of Arsenic Trioxide on K562 Cell Proliferation and Its Mechanisms]

Fan-Ping Wang1, Jing-Jing Zhang2, Li-Min Fang2

  • 1School of Laboratorial Medicine, Xinxiang Medical University; Collaborative Innovation Center of Molecular Diagnosis and Laboratorial Medicine of Henan Province, Xinxiang 453003, Henan Province, China.

Abstract

Insights

Arsenic trioxide (As2O3) inhibits K562 cell proliferation and induces apoptosis. This effect is linked to the regulation of CyclinD1 expression, a key cell cycle protein.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • K562 cells are a human chronic myeloid leukemia cell line.
  • Cell cycle dysregulation is a hallmark of cancer.
  • Arsenic trioxide is a known chemotherapeutic agent.

Purpose of the Study:

  • To investigate the anti-proliferative and apoptotic effects of arsenic trioxide (As2O3) on K562 cells.
  • To determine the role of cell cycle protein D1 and p27kip1 in As2O3-induced effects.

Main Methods:

  • MTT assay for cell proliferation.
  • Microscopy for apoptosis assessment.
  • RT-PCR, immunohistochemistry, and Western blot for protein expression analysis.

Main Results:

  • As2O3 inhibited K562 cell proliferation in a dose- and time-dependent manner.
  • Significant increase in K562 cell apoptosis observed with As2O3 treatment.
  • As2O3 markedly inhibited CyclinD1 expression, but not p27kip1.

Conclusions:

  • Arsenic trioxide effectively inhibits K562 cell proliferation.
  • As2O3 induces apoptosis in K562 cells.
  • Regulation of CyclinD1 expression is a key mechanism for As2O3's anti-cancer effects.